Emily Field
US biopharmaceuticals equity research analyst specializing in obesity therapeutics and pharma market dynamics, providing detailed analysis of drug launches, pricing and competitive outlook.
Best podcasts with Emily Field
Ranked by the Snipd community
8 snips
Mar 3, 2026 • 14min
Weight loss drugs: Scaling up
Emily Field, a US biopharmaceuticals equity research analyst focused on obesity therapeutics, breaks down the market transformation driven by GLP-1s. She explains why oral pills will expand the treated population. She discusses pricing pressure, direct‑to‑consumer moves and who might enter the market. She flags commercial capability and upcoming launches as key milestones.
